People · Operator
Named in public records as an officer, director or promoter · active 2015–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ImmuneXcite, Inc. | — | Biotechnology | Series A | $17.6M | $96.6M | 2015 |
| Ingenia Therapeutics Inc. | — | Biotechnology | Series A | $16.8M | $26.9M | 2022 |
| Mosaic Biosciences, Inc. | — | Biotechnology | Series A | $14.7M | $176.1M | 2022 |
Eric Furfine at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Eric Furfine on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ann DeWitt | 1 | 10 |
| John Edwards | 1 | 8 |
| Augustine Lawlor | 1 | 8 |
| Mark Lupa | 1 | 5 |
| Eric Rowinsky | 1 | 4 |
| Nassim Usman | 1 | 4 |
| Jeanette Welsh | 1 | 3 |
| Guy Katsav | 1 | 3 |
| James Geraghty | 1 | 3 |
| Rob Capone | 1 | 2 |
| Dan Mitchell | 1 | 2 |
| Valerie Friedman | 1 | 2 |
| Martin Stanton | 1 | 1 |
| Sang Gyun Kim | 1 | 1 |
| Joo Hee Kwak | 1 | 1 |
| Sangyeul Han | 1 | 1 |
| Kwang Ho Cheong | 1 | 1 |
| Sung Jae Kim | 1 | 1 |
| Heewon Park | 1 | 1 |
| Minji Kim | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.